Why attend TTLC 2022?
Presentations will summarize information about ongoing clinical trials of the newest therapies for lung cancer including data on preclinical and early clinical data.
Connect & Collaborate
Build connections with colleagues from around the world including prominent researchers and physicians.
Present & Discuss
Showcase your research and contribute to discussions that will shape the future of treatments in lung cancer and thoracic malignancies.
Advertising, Promotion & Exhibits
Market to one of the most unique gatherings of researchers, clinicians and professionals in the field of lung cancer and thoracic oncology.
|November 1, 2021||Abstract Submission Opens|
|December 1, 2021||Registration Opens|
|December 3, 2021 |
|Abstract Submission Deadline|
|December 20, 2021||Abstract Notifications of Acceptance/Rejection|
|February 9, 2022 |
|Presenting Author Registration Deadline|
|February 11, 2022||Full Abstract Release|
|February 22 – 26, 2022||Meeting|
TTLC 2022 Will Be Going Hybrid!
The longstanding highly interactive virtual meeting will feature novel research on emerging combination immunotherapy approaches and targets. Join us to meet professionals from around the world from the comfort of your own home.